A 14 Week Open-Label Study to Evaluate the Tolerability of Switching From an SSRI to Tiagabine(GABITRIL) in Order to Alleviate SSRI Induced Sexual Dysfunction in Generalized Anxiety Disorder Patients.
Phase of Trial: Phase IV
Latest Information Update: 13 Oct 2009
At a glance
- Drugs Tiagabine (Primary)
- Indications Generalised anxiety disorder
- Focus Adverse reactions
- 11 Oct 2008 New trial record.